Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | LC|no2024090908 (VIAF cluster) (Authority/Source Record) | ||
| 005 | 20240822053139.0 | ||
| 008 | 240820n| azannaabn |n aaa c | ||
| 003 | LC | ||
| 035 | ‡a (LC)12486407 | ||
| 010 | ‡a no2024090908 | ||
| 035 | ‡a (OCoLC)oca16344066 | ||
| 035 | ‡a (DLC)12492080 | ||
| 035 | ‡a (DLC)no2024090908 | ||
| 040 | ‡a GU ‡b eng ‡e rda ‡c GU | ||
| 100 | 1 | ‡a Moraga-Espinoza, Daniel | |
| 370 | ‡f Valparaíso (Chile) ‡2 naf | ||
| 670 | ‡a Essential pharmaceutics, 2024: ‡b t.p. (Daniel Moraga-Espinoza) t.p. verso (Daniel Moraga-Espinoza, University of Valparaíso, Valparaíso, Chile) | ||
| 919 | ‡a essentialpharmaceutics ‡A Essential pharmaceutics, 2024: ‡9 1 | ||
| 943 | ‡a 202x ‡A 2024 ‡9 1 | ||
| 996 | ‡2 SUDOC|096645776 | ||
| 996 | ‡2 RERO|A011483284 | ||
| 996 | ‡2 WKP|Q108531424 | ||
| 996 | ‡2 WKP|Q85356313 | ||
| 996 | ‡2 ISNI|000000007725347X | ||
| 996 | ‡2 WKP|Q56518727 | ||
| 996 | ‡2 BNCHL|10000000000000000287449 | ||
| 996 | ‡2 DNB|1220378518 | ||
| 996 | ‡2 J9U|987012901372905171 | ||
| 996 | ‡2 BNCHL|10000000000000000803434 | ||
| 996 | ‡2 BNCHL|10000000000000000273569 | ||
| 996 | ‡2 WKP|Q9353647 | ||
| 996 | ‡2 WKP|Q5798318 | ||
| 996 | ‡2 BNE|XX981406 | ||
| 996 | ‡2 WKP|Q104741597 | ||
| 996 | ‡2 WKP|Q5237691 | ||
| 996 | ‡2 DNB|1154826481 | ||
| 996 | ‡2 SUDOC|266174582 | ||
| 996 | ‡2 DNB|1061065391 | ||
| 996 | ‡2 ISNI|0000000025455432 | ||
| 996 | ‡2 BLBNB|001648045 | ||
| 996 | ‡2 BNCHL|10000000000000000850960 | ||
| 996 | ‡2 WKP|Q26206011 | ||
| 996 | ‡2 ISNI|0000000443360655 | ||
| 996 | ‡2 WKP|Q98885821 | ||
| 996 | ‡2 NUKAT|n 2012071950 | ||
| 996 | ‡2 BNCHL|10000000000000000833858 | ||
| 996 | ‡2 ISNI|0000000500041555 | ||
| 996 | ‡2 SZ|1154826481 | ||
| 996 | ‡2 SUDOC|191454311 | ||
| 996 | ‡2 WKP|Q55687873 | ||
| 996 | ‡2 BNE|XX4895433 | ||
| 996 | ‡2 WKP|Q62607086 | ||
| 996 | ‡2 DNB|132634856 | ||
| 996 | ‡2 BLBNB|000477013 | ||
| 996 | ‡2 WKP|Q81402816 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
